Drug Type Chemical drugs |
Synonyms ST205/ST114, SURIO 001, SURIO001 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | - | - | |
| Advanced Malignant Solid Neoplasm | IND Approval | China | 09 Sep 2025 | |
| Bile Duct Neoplasms | IND Application | China | 01 Jun 2025 | |
| Ovarian Cancer | IND Application | China | 01 Jun 2025 | |
| Stomach Cancer | IND Application | China | 01 Jun 2025 |





